Suzhou Sepax Technologies
688758
Juneway Electronic Technology
301458
Jiujiang Defu Technology
301511
Cubic Digital Technology
300344
Ningbo Shuanglin Auto Parts
300100
CN Stock MarketDetailed Quotes
300878 Zhejiang Wecome Pharmaceutical
- 14.00
- -0.74-5.02%
Market Closed Jan 10 15:00 CST
2.03BMarket Cap-60.87P/E (TTM)
14.77High14.00Low21.97KlotVolume14.70Open14.74Pre Close31.48MTurnover1.52%Turnover RatioLossP/E (Static)144.79MShares24.3852wk High1.50P/B2.02BFloat Cap13.3152wk Low17.69Limit Up144.12MShs Float59.90Historical High11.79Limit Down5.22%Amplitude13.31Historical Low0.25Dividend TTM14.33Avg Price11.68KlotAsk1.79%Div YieldTTM100Lot Size9.16KlotBid
Zhejiang Wecome Pharmaceutical News
Weikang Pharmaceutical: Announcement on the receipt by the company and the actual controller of the “Notice of Case Filing” from the China Securities Regulatory Commission
Weikang Pharmaceutical: Announcement on Release of Pledges for Some Shares of Controlling Shareholders and Actual Controllers
Weikang Pharmaceutical: Announcement on partial share pledges by controlling shareholders and actual controllers
Weikang Pharmaceutical: Announcement on changes in the company\'s drug production license
Weikang Pharmaceutical: Announcement on changes in the company\'s drug production license
Weikang Pharmaceutical: Announcement on Using Idle Own Funds for Entrusted Financial Management
Weikang Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Weikang Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Directors
Weikang Pharmaceutical: Report for the third quarter of 2024
Weikang Pharmaceutical: Announcement on the progress of the transfer of shares in the company\'s wholly-owned subsidiary
Weikang Pharmaceutical: Announcement on changes in the company\'s drug production license
Weikang Pharmaceutical: Minsheng Securities Co., Ltd.\'s inspection opinion on the extension of some fund-raising investment projects of Zhejiang Weikang Pharmaceutical Co., Ltd.
Weikang Pharmaceutical: Announcement on the postponement of some fund-raising investment projects
Weikang Pharmaceutical: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Weikang Pharmaceutical: 2024 Semi-Annual Report
Weikang Pharmaceutical: Announcement of Supervisory Committee Resolutions
Weikang Pharmaceutical: Table of non-operating capital occupation and other related capital transactions of Weikang Pharmaceutical for the first half year of 2024
Weikang Pharmaceutical: 2024 Semi-Annual Report Summary
Weikang Pharmaceutical: Announcement of Board Resolutions
Zhejiang Wecome Pharmaceutical: Announcement regarding the progress of the transfer of equity of a wholly-owned subsidiary of the company.
